Evidence map›Paper›PMID 28991246›Full record

ArticleBone marrow transplantation2018

Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation.

C Ustun, C Brunstein, T DeFor, A Rashidi, S Yohe, N Bejanyan, S Cooley, E Warlick, J Miller, M A Linden and 1 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

C UstunDivision of Hematology-Oncology and Transplantation, Department of Medicine, Minneapolis, MN, USA.
C BrunsteinDivision of Hematology-Oncology and Transplantation, Department of Medicine, Minneapolis, MN, USA.
T DeForBiostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
A RashidiDivision of Hematology-Oncology and Transplantation, Department of Medicine, Minneapolis, MN, USA.
S YoheDepartment of Pathology and Laboratory Medicine, University of Minnesota, Minneapolis, MN, USA.
N BejanyanDivision of Hematology-Oncology and Transplantation, Department of Medicine, Minneapolis, MN, USA.
S CooleyDivision of Hematology-Oncology and Transplantation, Department of Medicine, Minneapolis, MN, USA.
E WarlickDivision of Hematology-Oncology and Transplantation, Department of Medicine, Minneapolis, MN, USA.
J MillerDivision of Hematology-Oncology and Transplantation, Department of Medicine, Minneapolis, MN, USA.
M A LindenDepartment of Pathology and Laboratory Medicine, University of Minnesota, Minneapolis, MN, USA.
D WeisdorfDivision of Hematology-Oncology and Transplantation, Department of Medicine, Minneapolis, MN, USA.

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller · 1998 to 2026
$100.4M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cord Blood Stem Cell TransplantationFemaleHumansMaleNeoplasm, ResidualReceptors, KIRTransplantation ConditioningReceptors, KIR

Identifiers

PMID28991246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.